Literature DB >> 8709852

Fnr activates transcription from the P6 promoter of the pfl operon in vitro.

M Kaiser1, G Sawers.   

Abstract

Expression of the Escherichia coli focA-pfl operon is induced by anaerobiosis and transcription is controlled by seven promoters. Anaerobic induction is mediated by the ArcA and Fnr transcription factors. Fnr was purified and its specific interaction with the pfl promoter-regulatory region was characterized. A single binding site could be identified by DNase I footprinting, which was centred at -40.5 bp relative to the start site of promoter 6 (P6) transcription. Activation of P6 transcription in vitro was completely dependent on the Fnr protein. Fnr-dependent transcription could be prevented by mutating the Fnr-binding site, indicating that Fnr must bind to its recognition sequence to be able to activate transcription. An Fnr-independent promoter, which overlaps the P6 promoter, was also identified and characterized in vivo and in vitro. Transcription from this promoter (termed P6A) initiated 10 bp upstream of the P6 start site and assures that low-level synthesis of the FocA protein occurs under aerobic growth conditions.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8709852     DOI: 10.1111/j.1365-2958.1995.mmi_18020331.x

Source DB:  PubMed          Journal:  Mol Microbiol        ISSN: 0950-382X            Impact factor:   3.501


  3 in total

1.  Cloning, expression, and characterization of the Lactococcus lactis pfl gene, encoding pyruvate formate-lyase.

Authors:  J Arnau; F Jørgensen; S M Madsen; A Vrang; H Israelsen
Journal:  J Bacteriol       Date:  1997-09       Impact factor: 3.490

2.  Expression of fnr is constrained by an upstream IS5 insertion in certain Escherichia coli K-12 strains.

Authors:  R Gary Sawers
Journal:  J Bacteriol       Date:  2005-04       Impact factor: 3.490

3.  Pyruvate formate lyase is required for pneumococcal fermentative metabolism and virulence.

Authors:  Hasan Yesilkaya; Francesca Spissu; Sandra M Carvalho; Vanessa S Terra; Karen A Homer; Rachel Benisty; Nurith Porat; Ana R Neves; Peter W Andrew
Journal:  Infect Immun       Date:  2009-09-14       Impact factor: 3.441

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.